{"id":"placebo-of-clopidogrel-and-asprin","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are designed to be indistinguishable from active clopidogrel and aspirin but contain no pharmacologically active ingredients. They serve as the control comparator in phase 3 trials to measure the true clinical benefit of dual antiplatelet therapy (DAPT) by accounting for placebo effect and natural disease progression.","oneSentence":"This is a placebo control arm containing inactive formulations of clopidogrel and aspirin used in a clinical trial to establish efficacy of the active antiplatelet agents.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T01:28:11.785Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control arm in phase 3 trial evaluating dual antiplatelet therapy (likely acute coronary syndrome, stroke prevention, or stent thrombosis prevention)"}]},"trialDetails":[{"nctId":"NCT00979589","phase":"PHASE3","title":"Clopidogrel in High-risk Patients With Acute Non-disabling Cerebrovascular Events","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2009-12","conditions":"Stroke, Transient Ischemic Attack","enrollment":5100}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Acetylsalicylic acid"],"phase":"phase_3","status":"active","brandName":"Placebo of clopidogrel and Asprin","genericName":"Placebo of clopidogrel and Asprin","companyName":"Beijing Tiantan Hospital","companyId":"beijing-tiantan-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a placebo control arm containing inactive formulations of clopidogrel and aspirin used in a clinical trial to establish efficacy of the active antiplatelet agents. Used for Control arm in phase 3 trial evaluating dual antiplatelet therapy (likely acute coronary syndrome, stroke prevention, or stent thrombosis prevention).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}